vs
Side-by-side financial comparison of PHIBRO ANIMAL HEALTH CORP (PAHC) and Uniti Group Inc. (UNIT). Click either name above to swap in a different company.
Uniti Group Inc. is the larger business by last-quarter revenue ($722.6M vs $373.9M, roughly 1.9× PHIBRO ANIMAL HEALTH CORP). Uniti Group Inc. runs the higher net margin — 222.7% vs 7.3%, a 215.3% gap on every dollar of revenue.
Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock. The company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived. The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific. It is incorporated ...
Uniti was an electric vehicle prototype by Uniti Sweden, a Swedish automotive startup. The company was founded in January 2016 by a team of students and engineers under CEO Lewis Horne which aimed at developing an electric microcar in Lund, Sweden. It filed for bankruptcy in April 2022. No products were ever delivered to customers.
PAHC vs UNIT — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $373.9M | $722.6M |
| Net Profit | $27.5M | $1.6B |
| Gross Margin | 35.5% | — |
| Operating Margin | 13.5% | -5.9% |
| Net Margin | 7.3% | 222.7% |
| Revenue YoY | 20.9% | — |
| Net Profit YoY | 762.1% | — |
| EPS (diluted) | $0.67 | $4.92 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $373.9M | — | ||
| Q3 25 | $363.9M | $722.6M | ||
| Q2 25 | $378.7M | — | ||
| Q1 25 | $347.8M | — | ||
| Q4 24 | $309.3M | — | ||
| Q3 24 | $260.4M | — | ||
| Q2 24 | $273.2M | — | ||
| Q1 24 | $263.2M | — |
| Q4 25 | $27.5M | — | ||
| Q3 25 | $26.5M | $1.6B | ||
| Q2 25 | $17.2M | — | ||
| Q1 25 | $20.9M | — | ||
| Q4 24 | $3.2M | — | ||
| Q3 24 | $7.0M | — | ||
| Q2 24 | $752.0K | — | ||
| Q1 24 | $8.4M | — |
| Q4 25 | 35.5% | — | ||
| Q3 25 | 32.9% | — | ||
| Q2 25 | 29.0% | — | ||
| Q1 25 | 30.1% | — | ||
| Q4 24 | 32.9% | — | ||
| Q3 24 | 32.1% | — | ||
| Q2 24 | 31.9% | — | ||
| Q1 24 | 30.2% | — |
| Q4 25 | 13.5% | — | ||
| Q3 25 | 14.1% | -5.9% | ||
| Q2 25 | 8.9% | — | ||
| Q1 25 | 9.6% | — | ||
| Q4 24 | 8.3% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 6.7% | — | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 7.3% | — | ||
| Q3 25 | 7.3% | 222.7% | ||
| Q2 25 | 4.5% | — | ||
| Q1 25 | 6.0% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 3.2% | — |
| Q4 25 | $0.67 | — | ||
| Q3 25 | $0.65 | $4.92 | ||
| Q2 25 | $0.43 | — | ||
| Q1 25 | $0.51 | — | ||
| Q4 24 | $0.08 | — | ||
| Q3 24 | $0.17 | — | ||
| Q2 24 | $0.02 | — | ||
| Q1 24 | $0.21 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.5M | $158.0M |
| Total DebtLower is stronger | $624.2M | $9.3B |
| Stockholders' EquityBook value | $332.4M | $680.7M |
| Total Assets | $1.4B | $12.1B |
| Debt / EquityLower = less leverage | 1.88× | 13.64× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.5M | — | ||
| Q3 25 | $85.3M | $158.0M | ||
| Q2 25 | $77.0M | — | ||
| Q1 25 | $70.4M | — | ||
| Q4 24 | $67.1M | — | ||
| Q3 24 | $89.8M | — | ||
| Q2 24 | $114.6M | — | ||
| Q1 24 | $98.7M | — |
| Q4 25 | $624.2M | — | ||
| Q3 25 | $628.0M | $9.3B | ||
| Q2 25 | $631.7M | — | ||
| Q1 25 | $635.4M | — | ||
| Q4 24 | $639.1M | — | ||
| Q3 24 | $295.2M | — | ||
| Q2 24 | $312.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $332.4M | — | ||
| Q3 25 | $311.7M | $680.7M | ||
| Q2 25 | $285.7M | — | ||
| Q1 25 | $266.0M | — | ||
| Q4 24 | $246.8M | — | ||
| Q3 24 | $258.5M | — | ||
| Q2 24 | $256.6M | — | ||
| Q1 24 | $270.1M | — |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $12.1B | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $966.3M | — | ||
| Q2 24 | $982.2M | — | ||
| Q1 24 | $979.0M | — |
| Q4 25 | 1.88× | — | ||
| Q3 25 | 2.01× | 13.64× | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 2.39× | — | ||
| Q4 24 | 2.59× | — | ||
| Q3 24 | 1.14× | — | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.4M | $229.8M |
| Free Cash FlowOCF − Capex | $8.3M | — |
| FCF MarginFCF / Revenue | 2.2% | — |
| Capex IntensityCapex / Revenue | 3.0% | — |
| Cash ConversionOCF / Net Profit | 0.70× | 0.14× |
| TTM Free Cash FlowTrailing 4 quarters | $47.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.4M | — | ||
| Q3 25 | $9.3M | $229.8M | ||
| Q2 25 | $21.3M | — | ||
| Q1 25 | $43.2M | — | ||
| Q4 24 | $3.1M | — | ||
| Q3 24 | $12.6M | — | ||
| Q2 24 | $28.4M | — | ||
| Q1 24 | $11.4M | — |
| Q4 25 | $8.3M | — | ||
| Q3 25 | $-4.5M | — | ||
| Q2 25 | $8.1M | — | ||
| Q1 25 | $35.4M | — | ||
| Q4 24 | $-4.7M | — | ||
| Q3 24 | $3.0M | — | ||
| Q2 24 | $15.4M | — | ||
| Q1 24 | $1.7M | — |
| Q4 25 | 2.2% | — | ||
| Q3 25 | -1.2% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 10.2% | — | ||
| Q4 24 | -1.5% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 5.6% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | 3.0% | — | ||
| Q3 25 | 3.8% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 3.7% | — | ||
| Q2 24 | 4.8% | — | ||
| Q1 24 | 3.7% | — |
| Q4 25 | 0.70× | — | ||
| Q3 25 | 0.35× | 0.14× | ||
| Q2 25 | 1.24× | — | ||
| Q1 25 | 2.07× | — | ||
| Q4 24 | 0.97× | — | ||
| Q3 24 | 1.81× | — | ||
| Q2 24 | 37.80× | — | ||
| Q1 24 | 1.36× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PAHC
| Medicated Feed Additives And Others | $202.1M | 54% |
| Mineral Nutrition | $68.9M | 18% |
| Nutritional Specialties | $50.2M | 13% |
| Vaccines | $37.6M | 10% |
| Performance Products | $15.0M | 4% |
UNIT
| Revenue And Sales | $315.5M | 44% |
| DSL Subscriber And Other | $102.7M | 14% |
| Fiber Subscriber | $77.7M | 11% |
| Business Services | $66.4M | 9% |
| Uniti Fiber | $55.7M | 8% |
| Wholesale | $54.8M | 8% |
| Sales Revenue | $27.3M | 4% |
| Time Division Multiplexing | $8.7M | 1% |
| Switched Access | $2.2M | 0% |
